Your browser is no longer supported. Please, upgrade your browser.
Settings
VAR Varian Medical Systems, Inc. daily Stock Chart
VAR [NYSE]
Varian Medical Systems, Inc.
IndexS&P 500 P/E34.74 EPS (ttm)3.65 Insider Own0.20% Shs Outstand91.69M Perf Week4.78%
Market Cap11.63B Forward P/E26.38 EPS next Y4.81 Insider Trans-51.59% Shs Float91.16M Perf Month2.07%
Income337.30M PEG4.34 EPS next Q1.04 Inst Own- Short Float3.65% Perf Quarter15.72%
Sales2.73B P/S4.25 EPS this Y-18.70% Inst Trans-0.41% Short Ratio4.49 Perf Half Y21.68%
Book/sh15.14 P/B8.37 EPS next Y10.71% ROA3.70% Target Price114.75 Perf Year43.02%
Cash/sh- P/C- EPS next 5Y8.00% ROE8.40% 52W Range87.49 - 130.29 Perf YTD14.07%
Dividend- P/FCF26.14 EPS past 5Y-6.10% ROI13.60% 52W High-2.91% Beta0.84
Dividend %- Quick Ratio1.20 Sales past 5Y-1.00% Gross Margin43.20% 52W Low44.59% ATR2.38
Employees6600 Current Ratio1.50 Sales Q/Q12.80% Oper. Margin16.00% RSI (14)63.64 Volatility1.71% 2.00%
OptionableYes Debt/Eq0.25 EPS Q/Q- Profit Margin4.30% Rel Volume0.67 Prev Close126.79
ShortableYes LT Debt/Eq0.00 EarningsApr 25 AMC Payout0.00% Avg Volume741.51K Price126.50
Recom2.50 SMA204.42% SMA504.29% SMA20014.48% Volume497,010 Change-0.23%
Jan-25-18Upgrade Barrington Research Mkt Perform → Outperform $130
Jan-03-18Initiated Evercore ISI Underperform
Sep-07-17Downgrade BTIG Research Buy → Neutral
May-16-17Initiated Goldman Neutral $92
May-08-17Upgrade Citigroup Neutral → Buy
Apr-27-17Reiterated RBC Capital Mkts Sector Perform $82 → $90
Apr-27-17Downgrade Barrington Research Outperform → Mkt Perform
Jan-27-17Reiterated Barrington Research Outperform $102 → $98
Jan-23-17Reiterated RBC Capital Mkts Sector Perform $91 → $93
Jul-28-16Reiterated Barrington Research Outperform $93 → $102
Feb-17-16Reiterated RBC Capital Mkts Sector Perform $86 → $84
Jan-12-16Resumed Barrington Research Outperform $91
Dec-22-15Initiated RBC Capital Mkts Sector Perform $86
Nov-12-15Initiated Citigroup Neutral
Oct-20-15Downgrade Robert W. Baird Outperform → Neutral $101 → $82
Sep-28-15Downgrade Goldman Neutral → Sell
Jun-18-15Initiated Dougherty & Company Buy $105
Apr-30-15Downgrade JP Morgan Overweight → Neutral
Jan-29-15Reiterated Brean Capital Buy $87 → $96
Oct-23-14Reiterated ISI Group Neutral $86 → $82.50
Apr-20-18 08:15AM  Varian Calypso Anchored Beacon Transponder for Lung Receives FDA 510k Clearance PR Newswire
Apr-19-18 08:20AM  Varian to Demonstrate Advanced Cancer Care Solutions at ESTRO 37 PR Newswire
08:15AM  Varian Expands Capabilities of Halcyon Treatment System with New Imaging Technologies PR Newswire
Apr-18-18 08:15AM  Varian Wins "Best After-Sales Service Performance Award for Radiotherapy Products" in China PR Newswire
Apr-17-18 09:59AM  Varian Medical (VAR) Q2 Earnings: Is a Surprise in Store? Zacks
Apr-11-18 09:08AM  Varian Medical (VAR) Launches Velocity 4.0, Shares Rise Zacks
Apr-10-18 08:41AM  Here's Why You Should Hold on to Varian Medical Stock Now Zacks
Apr-09-18 08:15AM  Varian Launches Velocity 4.0 Cancer Imaging Software with Selective Internal Radiation Therapy Dosimetry Analysis PR Newswire
Mar-27-18 11:00AM  Here's Why You Should Invest in athenaheath Stock Right Now Zacks
08:15AM  Varian Eclipse Customers Take Top Overall Spots at World Championships of Treatment Planning PR Newswire
Mar-26-18 11:06AM  Why Should You Add Haemonetics (HAE) to Your Portfolio Now? Zacks
10:12AM  Neogen (NEOG) Q3 Earnings Beat, Revenues Miss Estimates Zacks
Mar-23-18 09:40AM  FDA Nod for Orthofix's G-Beam to Boost Extremity Fixation SBU Zacks
Mar-22-18 12:17PM  IBA swings to 2017 loss, looks for improvement this year Reuters
10:09AM  Baxter (BAX) Closes Acquisition of RECOTHROM & PREVELEAK Zacks
Mar-21-18 10:48AM  Boston Scientific's Positive Trial Results to Boost EP Unit Zacks
10:10AM  Wright Medical (WMGI) Poised on Acquisitions Amid Forex Woes Zacks
09:42AM  Varian Medical's ProBeam Platform Gains Traction in Russia Zacks
Mar-20-18 12:10PM  FDA Nod for Edwards' Acumen HPI Software Widens Portfolio Zacks
10:56AM  Here's Why You Should Invest in Baxter International Now Zacks
10:09AM  Abbott's MitraClip Therapy Wins Reimbursement Nod From MHLW Zacks
08:15AM  Varian-Equipped St. Petersburg Proton Therapy Center Completes First Patient Treatment PR Newswire
Mar-16-18 10:21AM  Here's Why You Should Invest in Varian Medical Right Now Zacks
Mar-15-18 10:01AM  Varian Medical Receives Regulatory Nod for Sirtex Buyout Zacks
Mar-14-18 04:15PM  Varian Announces Receipt of US and German Antitrust Clearances for Sirtex Acquisition PR Newswire
Mar-13-18 09:36AM  Varian (VAR) to Equip 7 Centers in Mexico, Expand in Oncology Zacks
Mar-12-18 04:09PM  Varian Announces Second Quarter Fiscal Year 2018 Earnings Release Date PR Newswire
Mar-09-18 05:01PM  Varian Selected by the Instituto Mexicano del Seguro Social (IMSS) to Equip Seven Treatment Centers in Mexico with Advanced Radiotherapy Technology PR Newswire
Mar-08-18 04:18PM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of Varian Medical Systems, Inc. (VAR) Investors Business Wire
Mar-05-18 09:08AM  Varian (VAR) Rides on Diverse Product Line, Competition Rife Zacks
08:15AM  Varian And University Of Maryland School Of Medicine Reach Milestone In Training Medical Professionals At Maryland Proton Treatment Center PR Newswire
Mar-01-18 04:09PM  Varian to Present at Barclays Global Healthcare Conference PR Newswire
10:09AM  Zacks Industry Outlook Highlights: Abbott, Becton and Dickinson, Stryker, Varian Medical and Boston Scientific Zacks
Feb-26-18 08:15AM  Varian to Showcase Software Solutions for Smarter Cancer Care at HIMSS18 PR Newswire
Feb-23-18 10:07AM  Varian Medical (VAR) Down 5.7% Since Earnings Report: Can It Rebound? Zacks
09:16AM  Varian (VAR) Acquires Evinance to Boost Oncology Segment Zacks
Feb-22-18 02:21PM  Varian ARIA Oncology Information System Earns ONC Health IT Certification from Drummond Group LLC PR Newswire
08:10AM  Varian Acquires Evinance Innovation, Inc. PR Newswire
Feb-20-18 08:15AM  Varian ARIA, Eclipse and TrueBeam Named Category Leaders in the 2018 Best in KLAS: Software and Services Report PR Newswire
Feb-15-18 02:37PM  Pinecrest Completes Strategic Sale of Mobius to Varian PR Newswire
Feb-06-18 08:15AM  Varian Halcyon Treatment System Receives AERB Certificate for Import & Supply in India PR Newswire
Feb-05-18 08:15AM  Varian Acquires Mobius Medical Systems PR Newswire
Jan-30-18 07:40AM  Free Research Report as Varians Adjusted EPS Surged 112% and Revenues Advanced 12.8% ACCESSWIRE
05:57AM  Varian Medical swoops on Australia's Sirtex as medical M&A soars Reuters
02:25AM  Varian Medical Systems to buy Australia's Sirtex Medical for about $1.3 bln Reuters
02:07AM  Varian to Buy Sirtex for $1.3 Billion to Add Cancer Drugs Bloomberg
02:04AM  Varian to Discuss Agreement to Acquire Sirtex PR Newswire
01:58AM  Varian Signs Agreement to Acquire Sirtex PR Newswire
Jan-26-18 11:15AM  Varian Medical Systems: S&P 500s Top Gainer on January 25 Market Realist
Jan-25-18 05:04PM  What Happened in the Stock Market Today Motley Fool +12.35%
04:39PM  The Hot Stock & Biggest Loser: Varian Medical & Newell Brands Barrons.com
11:20AM  Why Varian Medical Systems Is Soaring Today Motley Fool
09:15AM  Sylvester Comprehensive Cancer Center at University of Miami Purchases Varian ProBeam Compact Proton Therapy System PR Newswire
09:00AM  Varian Medical (VAR) Beats Q1 Earnings & Revenue Estimates Zacks
Jan-24-18 04:34PM  Varian Medical rockets higher than record after earnings MarketWatch
04:15PM  Varian Selected to Provide Compact Single-room System for First Proton Therapy Center in Alabama PR Newswire
04:09PM  Varian Reports Results for First Quarter of Fiscal Year 2018 PR Newswire
06:13AM  How Do Analysts See Varian Medical Systems Inc (NYSE:VAR) Performing Over The Next Few Years? Simply Wall St.
Jan-23-18 02:10PM  Intuitive Surgicals Da Vinci Procedure Could Boost 2017 Results Market Realist
08:25AM  Recent Analysis Shows Varian Medical, Deckers Outdoor, Copart, Systemax, TPG Specialty Lending, and Cohen & Steers Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Jan-22-18 10:34AM  What's in the Cards for Varian Medical (VAR) in Q1 Earnings? Zacks
Jan-19-18 05:50PM  Varian Medical Systems: Earnings Expected to Rise 26.8% in 1Q18 Market Realist
04:20PM  Will Varian Medical Systems Sales Decline Again in 1Q18? Market Realist
02:50PM  Analyst Recommendations for Varian Medical Systems before 1Q18 Market Realist
Jan-15-18 04:13AM  New Strong Sell Stocks for January 15th Zacks
Jan-09-18 08:26AM  New Strong Sell Stocks for January 9th Zacks
Jan-08-18 08:15AM  Varian and Ping An Sign Memorandum of Understanding to Expand Access to High Quality Cancer Care in China PR Newswire
08:10AM  Varian Halcyon Treatment System Receives Taiwan FDA Approval PR Newswire
Jan-03-18 04:09PM  Varian to Discuss New Reporting Standards PR Newswire
Jan-01-18 09:13AM  Varian Medical Systems, Inc. :VAR-US: Earnings Analysis: Q4, 2017 By the Numbers : January 1, 2018 Capital Cube
Dec-28-17 04:09PM  Varian Publishes 2017 Annual Report PR Newswire
07:32AM  How Has Varian Medical Systems Stock Been Performing Recently? Market Realist
Dec-27-17 01:00PM  How Varian Has Expanded Its Global Footprint Market Realist
11:30AM  Eclipse System Expands Varians Market Presence in Australia Market Realist
09:59AM  Discussing Analysts Latest Recommendations on VAR Stock Market Realist
Dec-18-17 11:15PM  Varian Medical Systems Inc (VAR) President and CEO Dow R Wilson Sold $9.9 million of Shares GuruFocus.com
04:05PM  Varian to Present at 36th Annual J.P. Morgan Healthcare Conference PR Newswire
08:22AM  Varian Gains Ground on New Applications, Grows in Australia Zacks
Dec-12-17 05:00PM  Peter MacCallum Cancer Centre Standardizes on Varian Solution for Cancer Treatment Planning PR Newswire
Dec-11-17 04:09PM  Varian Announces First Quarter Fiscal Year 2018 Earnings Release Date PR Newswire
Dec-08-17 08:31AM  Varian Halcyon Gets ANVISA Registration, Grows in Oncology Zacks
Dec-06-17 08:15AM  Varian Halcyon Treatment System Receives ANVISA Registration in Brazil PR Newswire
08:05AM  See what the IHS Markit Score report has to say about Varian Medical Systems Inc. Markit
Dec-05-17 09:01AM  Varians Latest Wall Street Recommendations: Mostly Hold Market Realist
08:05AM  See what the IHS Markit Score report has to say about Varian Medical Systems Inc. Markit
07:31AM  Varians Long-Term Growth Strategy: Will It Drive 2018 Guidance? Market Realist
Dec-04-17 10:32AM  A Look at Varian Medical Systems Long-Term Objectives Market Realist
09:02AM  Varian Medical Systems Profitability Profile Market Realist
08:05AM  See what the IHS Markit Score report has to say about Varian Medical Systems Inc. Markit
07:33AM  Varians Performance by Geography and Future Growth Potential Market Realist
01:20AM  Varian Partners with Penn Medicine for Proton Therapy Training and Education Program PR Newswire
Dec-01-17 11:40AM  Varians Halcyon System Sees Strong Global Growth Momentum Market Realist
10:10AM  How Double-Digit Orders Growth Is Driving Varian Medical Systems Market Realist
08:38AM  Varian Stock Rallied to 52-Week High on November 29 Market Realist
08:05AM  See what the IHS Markit Score report has to say about Varian Medical Systems Inc. Markit
Nov-30-17 08:43AM  Varian's Partners Penn Medicine, Proton Therapy in Focus Zacks
Nov-28-17 04:05PM  Varian Medical Systems Schedules Annual Stockholder Meeting In Palo Alto PR Newswire
08:16AM  Is Varian Medical Systems Incs (VAR) Liquidity As Good As Its Solvency? Simply Wall St.
08:15AM  Varian Partners with Penn Medicine for Proton Therapy Training and Education Program PR Newswire
08:00AM  Varian Medical Systems To Present At The Citi 2017 Global Healthcare Conference PR Newswire
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Varian Particle Therapy. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy. Its products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, and accessories; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, oncology practices, radiotherapy centers, and cancer care clinics. The Varian Particle Therapy segment develops, designs, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. Varian Medical Systems, Inc. has a strategic partnership with Siemens AG to co-develop new imaging and treatment solutions. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KUO JOHN WSVP, Gen Counsel and SecretaryApr 16Option Exercise71.771,32895,31131,173Apr 17 05:40 PM
KUO JOHN WSVP, Gen Counsel and SecretaryApr 16Sale121.941,328161,93529,845Apr 17 05:40 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Apr 10Option Exercise80.4069956,20027,361Apr 10 06:54 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Apr 10Sale120.3369984,11326,662Apr 10 06:54 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMar 15Option Exercise71.771,32895,31131,173Mar 15 08:47 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMar 15Sale125.511,328166,67229,845Mar 15 08:47 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Mar 12Option Exercise80.4069956,20027,361Mar 12 07:56 PM
MOMSEN MAGNUSSVP, CAO, Corporate ControllerMar 12Sale126.471,556196,7926,588Mar 12 08:00 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Mar 12Sale126.4769988,40126,662Mar 12 07:56 PM
ILLINGWORTH DAVID JDirectorMar 06Option Exercise57.275,651323,63312,737Mar 07 06:59 PM
ILLINGWORTH DAVID JDirectorMar 06Sale122.565,651692,5607,086Mar 07 06:59 PM
WILSON DOW RPresident and CEOMar 01Option Exercise74.0624,0001,777,44099,356Mar 02 06:08 PM
WILSON DOW RPresident and CEOMar 01Sale118.0324,0002,832,80275,356Mar 02 06:08 PM
BOSTROM SUSAN LDirectorFeb 22Sale120.601,952235,4133,809Feb 22 07:22 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Feb 16Sale121.163,513425,62226,662Feb 16 07:10 PM
KUO JOHN WSVP, Gen Counsel and SecretaryFeb 15Option Exercise78.626,442506,47632,940Feb 16 07:14 PM
KUO JOHN WSVP, Gen Counsel and SecretaryFeb 15Sale120.676,442777,34327,361Feb 16 07:14 PM
DUGAN REGINA EDirectorFeb 13Option Exercise0.001,95204,113Feb 14 09:12 PM
GUERTIN TIMOTHY EDirectorFeb 13Option Exercise0.001,95204,113Feb 14 09:09 PM
ILLINGWORTH DAVID JDirectorFeb 13Option Exercise0.001,95207,086Feb 14 09:06 PM
ECKERT R ANDREWDirectorFeb 13Option Exercise0.001,952010,551Feb 14 09:03 PM
BOSTROM SUSAN LDirectorFeb 13Option Exercise0.001,95205,761Feb 14 09:00 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Feb 12Option Exercise80.408,390674,55635,052Feb 13 06:47 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Feb 12Sale116.478,390977,16426,662Feb 13 06:47 PM
LARET MARK RDirectorFeb 08Option Exercise0.006,32606,326Feb 08 08:27 PM
WILSON DOW RPresident and CEOFeb 01Option Exercise74.0624,0001,777,44090,776Feb 02 07:13 PM
WILSON DOW RPresident and CEOFeb 01Sale126.7324,0003,041,46966,776Feb 02 07:13 PM
LARET MARK RDirectorFeb 01Sale126.972,161274,3830Feb 02 07:09 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jan 16Option Exercise81.9793376,47827,595Jan 17 06:58 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJan 16Option Exercise67.1286357,92528,224Jan 17 07:05 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJan 16Sale108.4386393,57527,361Jan 17 07:05 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jan 16Sale108.31933101,05626,662Jan 17 06:58 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jan 12Option Exercise67.121,08973,09427,751Jan 16 05:04 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jan 12Sale108.191,089117,82326,662Jan 16 05:04 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJan 08Option Exercise73.957,991590,94435,352Jan 10 03:05 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJan 08Sale110.657,991884,20027,361Jan 10 03:05 PM
GUERTIN TIMOTHY EDirectorJan 02Sale111.4610,0001,114,64165,800Jan 03 06:19 PM
WILSON DOW RPresident and CEODec 18Option Exercise60.9188,7665,406,737155,542Dec 18 09:24 PM
WILSON DOW RPresident and CEODec 18Sale111.0088,7669,852,93566,776Dec 18 09:24 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Dec 13Option Exercise81.9793176,31427,593Dec 13 08:41 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Dec 13Sale113.01931105,21026,662Dec 13 08:41 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Dec 12Option Exercise67.121,08772,95927,749Dec 13 08:41 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Dec 12Sale111.091,087120,75426,662Dec 13 08:41 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Nov 13Option Exercise73.982,021149,50527,750Nov 14 06:08 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Nov 13Sale107.362,021216,98326,662Nov 14 06:08 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Oct 18Option Exercise81.9793176,31427,531Oct 19 08:26 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Oct 18Sale105.0093197,75526,600Oct 19 08:26 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Oct 12Option Exercise67.121,08873,02727,688Oct 13 03:23 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Oct 12Sale101.551,088110,48926,600Oct 13 03:23 PM
WILSON DOW RPresident and CEOOct 06Option Exercise51.2315,059771,47381,835Oct 06 07:46 PM
ECKERT R ANDREWDirectorOct 06Option Exercise62.745,651354,54414,650Oct 06 07:55 PM
ECKERT R ANDREWDirectorOct 06Sale102.395,651578,5948,999Oct 06 07:55 PM
WILSON DOW RPresident and CEOOct 06Sale102.4015,0591,541,97866,776Oct 06 07:46 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Sep 13Option Exercise0.00933027,533Sep 14 11:36 AM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Sep 13Sale107.29933100,10026,600Sep 14 11:36 AM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Sep 12Option Exercise0.001,088027,688Sep 13 11:25 AM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Sep 12Sale107.331,088116,77826,600Sep 13 11:25 AM
WILSON DOW RPresident and CEOSep 07Option Exercise0.0015,059081,835Sep 08 03:05 PM
WILSON DOW RPresident and CEOSep 07Sale105.4115,0591,587,36766,776Sep 08 03:05 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Aug 31Option Exercise81.9793176,31427,531Sep 01 03:48 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Aug 31Sale105.0093197,75526,600Sep 01 03:48 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Aug 14Option Exercise67.121,08873,02726,600Aug 15 07:56 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Aug 14Sale97.911,088106,52526,600Aug 15 07:56 PM
WILSON DOW RPresident and CEOAug 07Option Exercise51.2315,059771,47381,835Aug 08 08:08 PM
WILSON DOW RPresident and CEOAug 07Sale96.4815,0591,452,89566,776Aug 08 08:08 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jul 13Option Exercise81.9793376,47827,533Jul 13 07:59 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJul 13Option Exercise81.9773460,16627,361Jul 13 08:08 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJul 13Sale104.3873476,61427,261Jul 13 08:08 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jul 13Sale105.0093397,96526,600Jul 13 07:59 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jul 12Option Exercise67.121,08873,02727,688Jul 13 07:59 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJul 12Option Exercise67.1286357,92528,224Jul 13 08:08 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJul 12Sale104.4886390,16627,361Jul 13 08:08 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jul 12Sale104.491,088113,69026,600Jul 13 07:59 PM
WILSON DOW RPresident and CEOJul 10Option Exercise51.2315,060771,52481,836Jul 11 07:26 PM
WILSON DOW RPresident and CEOJul 10Sale103.3715,0601,556,70166,776Jul 11 07:26 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jun 20Option Exercise81.9726,0922,138,76152,692Jun 21 04:49 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jun 20Sale105.0026,0922,739,66026,600Jun 21 04:49 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJun 13Option Exercise81.9773460,16628,095Jun 14 07:07 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJun 13Sale101.9173474,80027,361Jun 14 07:07 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jun 12Option Exercise67.121,08772,95927,687Jun 13 07:07 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJun 12Option Exercise67.1286357,92528,224Jun 13 07:11 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJun 12Sale101.2586387,37827,361Jun 13 07:11 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jun 12Sale101.201,087110,00026,600Jun 13 07:07 PM
GUERTIN TIMOTHY EDirectorJun 09Sale103.2216,0001,651,54675,800Jun 12 07:48 PM
LARET MARK RDirectorJun 08Sale103.471,428147,7612,161Jun 09 04:02 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jun 01Option Exercise70.6356,5733,995,84883,173Jun 02 06:59 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jun 01Sale99.7656,5735,643,90026,600Jun 02 06:59 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMay 31Option Exercise81.9719,8191,624,56347,180Jun 01 03:58 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMay 31Sale99.6719,8191,975,36027,361Jun 01 03:58 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMay 12Option Exercise67.1286257,85728,223May 12 06:48 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMay 12Sale96.3986283,08427,361May 12 06:48 PM
BOSTROM SUSAN LDirectorMay 02Sale91.083,589326,9023,809May 03 06:29 PM